Prenatal Diagnostics-North America Market Status and Trend Report 2013-2023
Report Summary
Prenatal Diagnostics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Prenatal Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Prenatal Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Prenatal Diagnostics in North America, with company and product introduction, position in the Prenatal Diagnostics market
Market status and development trend of Prenatal Diagnostics by types and applications
Cost and profit status of Prenatal Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the North America Prenatal Diagnostics market as:
North America Prenatal Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Prenatal Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Invasive
Non-invasive
North America Prenatal Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Others
North America Prenatal Diagnostics Market: Players Segment Analysis (Company and Product introduction, Prenatal Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care Inc (US)
Acon Laboratories Inc(US)
AgaMatrix Inc (US)
Alere Inc (US)
Animas Corporation (US)
Apex Biotechnology Corporation (Taiwan)
ARKRAY Inc (Japan)
Ascensia Diabetes Care Holdings AG (Switzerland)
A.Menarini Diagnostics Ltd (UK)
B. Braun Melsungen AG (Germany)
Becton, Dickinson and Company (US)
Bayer Healthcare Diabetes Care (US)
Beckman Coulter Inc (US)
Bio-Rad Laboratories (US)
BIONIME Corporation (Taiwan)
Diazyme Laboratories Inc (US)
Dexcom Inc(US)
EKF Diagnostics Holdings Plc (UK)
HemoCue(r) AB (Sweden)
Infopia Co Ltd(South Korea)
LifeScan Inc(US)
Medtronic MiniMed Inc(US)
Nova Biomedical Corporation (US)
PTS Diagnostics (US)
Roche Diagnostics (Switzerland)
Sanofi S.A. (France)
Sanwa Kagaku Kenkyusho Co Ltd(Japan)
Siemens Healthineers (Germany)
Taidoc Technology Corporation (Taiwan)
Terumo Corporation (Japan)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Prenatal Diagnostics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Prenatal Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Prenatal Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Prenatal Diagnostics in North America, with company and product introduction, position in the Prenatal Diagnostics market
Market status and development trend of Prenatal Diagnostics by types and applications
Cost and profit status of Prenatal Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the North America Prenatal Diagnostics market as:
North America Prenatal Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Prenatal Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Invasive
Non-invasive
North America Prenatal Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Others
North America Prenatal Diagnostics Market: Players Segment Analysis (Company and Product introduction, Prenatal Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care Inc (US)
Acon Laboratories Inc(US)
AgaMatrix Inc (US)
Alere Inc (US)
Animas Corporation (US)
Apex Biotechnology Corporation (Taiwan)
ARKRAY Inc (Japan)
Ascensia Diabetes Care Holdings AG (Switzerland)
A.Menarini Diagnostics Ltd (UK)
B. Braun Melsungen AG (Germany)
Becton, Dickinson and Company (US)
Bayer Healthcare Diabetes Care (US)
Beckman Coulter Inc (US)
Bio-Rad Laboratories (US)
BIONIME Corporation (Taiwan)
Diazyme Laboratories Inc (US)
Dexcom Inc(US)
EKF Diagnostics Holdings Plc (UK)
HemoCue(r) AB (Sweden)
Infopia Co Ltd(South Korea)
LifeScan Inc(US)
Medtronic MiniMed Inc(US)
Nova Biomedical Corporation (US)
PTS Diagnostics (US)
Roche Diagnostics (Switzerland)
Sanofi S.A. (France)
Sanwa Kagaku Kenkyusho Co Ltd(Japan)
Siemens Healthineers (Germany)
Taidoc Technology Corporation (Taiwan)
Terumo Corporation (Japan)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PRENATAL DIAGNOSTICS
1.1 Definition of Prenatal Diagnostics in This Report
1.2 Commercial Types of Prenatal Diagnostics
1.2.1 Invasive
1.2.2 Non-invasive
1.3 Downstream Application of Prenatal Diagnostics
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Development History of Prenatal Diagnostics
1.5 Market Status and Trend of Prenatal Diagnostics 2013-2023
1.5.1 North America Prenatal Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Prenatal Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Prenatal Diagnostics in North America 2013-2017
2.2 Consumption Market of Prenatal Diagnostics in North America by Regions
2.2.1 Consumption Volume of Prenatal Diagnostics in North America by Regions
2.2.2 Revenue of Prenatal Diagnostics in North America by Regions
2.3 Market Analysis of Prenatal Diagnostics in North America by Regions
2.3.1 Market Analysis of Prenatal Diagnostics in United States 2013-2017
2.3.2 Market Analysis of Prenatal Diagnostics in Canada 2013-2017
2.3.3 Market Analysis of Prenatal Diagnostics in Mexico 2013-2017
2.4 Market Development Forecast of Prenatal Diagnostics in North America 2018-2023
2.4.1 Market Development Forecast of Prenatal Diagnostics in North America 2018-2023
2.4.2 Market Development Forecast of Prenatal Diagnostics by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Prenatal Diagnostics in North America by Types
3.1.2 Revenue of Prenatal Diagnostics in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Prenatal Diagnostics in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Prenatal Diagnostics in North America by Downstream Industry
4.2 Demand Volume of Prenatal Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Prenatal Diagnostics by Downstream Industry in United States
4.2.2 Demand Volume of Prenatal Diagnostics by Downstream Industry in Canada
4.2.3 Demand Volume of Prenatal Diagnostics by Downstream Industry in Mexico
4.3 Market Forecast of Prenatal Diagnostics in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PRENATAL DIAGNOSTICS
5.1 North America Economy Situation and Trend Overview
5.2 Prenatal Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 PRENATAL DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Prenatal Diagnostics in North America by Major Players
6.2 Revenue of Prenatal Diagnostics in North America by Major Players
6.3 Basic Information of Prenatal Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Prenatal Diagnostics Major Players
6.3.2 Employees and Revenue Level of Prenatal Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PRENATAL DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Diabetes Care Inc (US)
7.1.1 Company profile
7.1.2 Representative Prenatal Diagnostics Product
7.1.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care Inc (US)
7.2 Acon Laboratories Inc(US)
7.2.1 Company profile
7.2.2 Representative Prenatal Diagnostics Product
7.2.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Acon Laboratories Inc(US)
7.3 AgaMatrix Inc (US)
7.3.1 Company profile
7.3.2 Representative Prenatal Diagnostics Product
7.3.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of AgaMatrix Inc (US)
7.4 Alere Inc (US)
7.4.1 Company profile
7.4.2 Representative Prenatal Diagnostics Product
7.4.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Alere Inc (US)
7.5 Animas Corporation (US)
7.5.1 Company profile
7.5.2 Representative Prenatal Diagnostics Product
7.5.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Animas Corporation (US)
7.6 Apex Biotechnology Corporation (Taiwan)
7.6.1 Company profile
7.6.2 Representative Prenatal Diagnostics Product
7.6.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Apex Biotechnology Corporation (Taiwan)
7.7 ARKRAY Inc (Japan)
7.7.1 Company profile
7.7.2 Representative Prenatal Diagnostics Product
7.7.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of ARKRAY Inc (Japan)
7.8 Ascensia Diabetes Care Holdings AG (Switzerland)
7.8.1 Company profile
7.8.2 Representative Prenatal Diagnostics Product
7.8.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Ascensia Diabetes Care Holdings AG (Switzerland)
7.9 A.Menarini Diagnostics Ltd (UK)
7.9.1 Company profile
7.9.2 Representative Prenatal Diagnostics Product
7.9.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of A.Menarini Diagnostics Ltd (UK)
7.10 B. Braun Melsungen AG (Germany)
7.10.1 Company profile
7.10.2 Representative Prenatal Diagnostics Product
7.10.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG (Germany)
7.11 Becton, Dickinson and Company (US)
7.11.1 Company profile
7.11.2 Representative Prenatal Diagnostics Product
7.11.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company (US)
7.12 Bayer Healthcare Diabetes Care (US)
7.12.1 Company profile
7.12.2 Representative Prenatal Diagnostics Product
7.12.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Bayer Healthcare Diabetes Care (US)
7.13 Beckman Coulter Inc (US)
7.13.1 Company profile
7.13.2 Representative Prenatal Diagnostics Product
7.13.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter Inc (US)
7.14 Bio-Rad Laboratories (US)
7.14.1 Company profile
7.14.2 Representative Prenatal Diagnostics Product
7.14.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories (US)
7.15 BIONIME Corporation (Taiwan)
7.15.1 Company profile
7.15.2 Representative Prenatal Diagnostics Product
7.15.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of BIONIME Corporation (Taiwan)
7.16 Diazyme Laboratories Inc (US)
7.17 Dexcom Inc(US)
7.18 EKF Diagnostics Holdings Plc (UK)
7.19 HemoCue(r) AB (Sweden)
7.20 Infopia Co Ltd(South Korea)
7.21 LifeScan Inc(US)
7.22 Medtronic MiniMed Inc(US)
7.23 Nova Biomedical Corporation (US)
7.24 PTS Diagnostics (US)
7.25 Roche Diagnostics (Switzerland)
7.26 Sanofi S.A. (France)
7.27 Sanwa Kagaku Kenkyusho Co Ltd(Japan)
7.28 Siemens Healthineers (Germany)
7.29 Taidoc Technology Corporation (Taiwan)
7.30 Terumo Corporation (Japan)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PRENATAL DIAGNOSTICS
8.1 Industry Chain of Prenatal Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PRENATAL DIAGNOSTICS
9.1 Cost Structure Analysis of Prenatal Diagnostics
9.2 Raw Materials Cost Analysis of Prenatal Diagnostics
9.3 Labor Cost Analysis of Prenatal Diagnostics
9.4 Manufacturing Expenses Analysis of Prenatal Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF PRENATAL DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Prenatal Diagnostics in This Report
1.2 Commercial Types of Prenatal Diagnostics
1.2.1 Invasive
1.2.2 Non-invasive
1.3 Downstream Application of Prenatal Diagnostics
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Development History of Prenatal Diagnostics
1.5 Market Status and Trend of Prenatal Diagnostics 2013-2023
1.5.1 North America Prenatal Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Prenatal Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Prenatal Diagnostics in North America 2013-2017
2.2 Consumption Market of Prenatal Diagnostics in North America by Regions
2.2.1 Consumption Volume of Prenatal Diagnostics in North America by Regions
2.2.2 Revenue of Prenatal Diagnostics in North America by Regions
2.3 Market Analysis of Prenatal Diagnostics in North America by Regions
2.3.1 Market Analysis of Prenatal Diagnostics in United States 2013-2017
2.3.2 Market Analysis of Prenatal Diagnostics in Canada 2013-2017
2.3.3 Market Analysis of Prenatal Diagnostics in Mexico 2013-2017
2.4 Market Development Forecast of Prenatal Diagnostics in North America 2018-2023
2.4.1 Market Development Forecast of Prenatal Diagnostics in North America 2018-2023
2.4.2 Market Development Forecast of Prenatal Diagnostics by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Prenatal Diagnostics in North America by Types
3.1.2 Revenue of Prenatal Diagnostics in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Prenatal Diagnostics in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Prenatal Diagnostics in North America by Downstream Industry
4.2 Demand Volume of Prenatal Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Prenatal Diagnostics by Downstream Industry in United States
4.2.2 Demand Volume of Prenatal Diagnostics by Downstream Industry in Canada
4.2.3 Demand Volume of Prenatal Diagnostics by Downstream Industry in Mexico
4.3 Market Forecast of Prenatal Diagnostics in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PRENATAL DIAGNOSTICS
5.1 North America Economy Situation and Trend Overview
5.2 Prenatal Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 PRENATAL DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Prenatal Diagnostics in North America by Major Players
6.2 Revenue of Prenatal Diagnostics in North America by Major Players
6.3 Basic Information of Prenatal Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Prenatal Diagnostics Major Players
6.3.2 Employees and Revenue Level of Prenatal Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PRENATAL DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Diabetes Care Inc (US)
7.1.1 Company profile
7.1.2 Representative Prenatal Diagnostics Product
7.1.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care Inc (US)
7.2 Acon Laboratories Inc(US)
7.2.1 Company profile
7.2.2 Representative Prenatal Diagnostics Product
7.2.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Acon Laboratories Inc(US)
7.3 AgaMatrix Inc (US)
7.3.1 Company profile
7.3.2 Representative Prenatal Diagnostics Product
7.3.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of AgaMatrix Inc (US)
7.4 Alere Inc (US)
7.4.1 Company profile
7.4.2 Representative Prenatal Diagnostics Product
7.4.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Alere Inc (US)
7.5 Animas Corporation (US)
7.5.1 Company profile
7.5.2 Representative Prenatal Diagnostics Product
7.5.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Animas Corporation (US)
7.6 Apex Biotechnology Corporation (Taiwan)
7.6.1 Company profile
7.6.2 Representative Prenatal Diagnostics Product
7.6.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Apex Biotechnology Corporation (Taiwan)
7.7 ARKRAY Inc (Japan)
7.7.1 Company profile
7.7.2 Representative Prenatal Diagnostics Product
7.7.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of ARKRAY Inc (Japan)
7.8 Ascensia Diabetes Care Holdings AG (Switzerland)
7.8.1 Company profile
7.8.2 Representative Prenatal Diagnostics Product
7.8.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Ascensia Diabetes Care Holdings AG (Switzerland)
7.9 A.Menarini Diagnostics Ltd (UK)
7.9.1 Company profile
7.9.2 Representative Prenatal Diagnostics Product
7.9.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of A.Menarini Diagnostics Ltd (UK)
7.10 B. Braun Melsungen AG (Germany)
7.10.1 Company profile
7.10.2 Representative Prenatal Diagnostics Product
7.10.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG (Germany)
7.11 Becton, Dickinson and Company (US)
7.11.1 Company profile
7.11.2 Representative Prenatal Diagnostics Product
7.11.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company (US)
7.12 Bayer Healthcare Diabetes Care (US)
7.12.1 Company profile
7.12.2 Representative Prenatal Diagnostics Product
7.12.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Bayer Healthcare Diabetes Care (US)
7.13 Beckman Coulter Inc (US)
7.13.1 Company profile
7.13.2 Representative Prenatal Diagnostics Product
7.13.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter Inc (US)
7.14 Bio-Rad Laboratories (US)
7.14.1 Company profile
7.14.2 Representative Prenatal Diagnostics Product
7.14.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories (US)
7.15 BIONIME Corporation (Taiwan)
7.15.1 Company profile
7.15.2 Representative Prenatal Diagnostics Product
7.15.3 Prenatal Diagnostics Sales, Revenue, Price and Gross Margin of BIONIME Corporation (Taiwan)
7.16 Diazyme Laboratories Inc (US)
7.17 Dexcom Inc(US)
7.18 EKF Diagnostics Holdings Plc (UK)
7.19 HemoCue(r) AB (Sweden)
7.20 Infopia Co Ltd(South Korea)
7.21 LifeScan Inc(US)
7.22 Medtronic MiniMed Inc(US)
7.23 Nova Biomedical Corporation (US)
7.24 PTS Diagnostics (US)
7.25 Roche Diagnostics (Switzerland)
7.26 Sanofi S.A. (France)
7.27 Sanwa Kagaku Kenkyusho Co Ltd(Japan)
7.28 Siemens Healthineers (Germany)
7.29 Taidoc Technology Corporation (Taiwan)
7.30 Terumo Corporation (Japan)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PRENATAL DIAGNOSTICS
8.1 Industry Chain of Prenatal Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PRENATAL DIAGNOSTICS
9.1 Cost Structure Analysis of Prenatal Diagnostics
9.2 Raw Materials Cost Analysis of Prenatal Diagnostics
9.3 Labor Cost Analysis of Prenatal Diagnostics
9.4 Manufacturing Expenses Analysis of Prenatal Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF PRENATAL DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
